94413-65-7

Usage

Uses

Used in Pharmaceutical Industry:
5-Aminomethyl-nicotinonitrile is used as a key component in the preparation of pharmaceutical drugs. Its unique structure allows it to modify and enhance the properties of certain drugs, improving their effectiveness and safety.
Used as an Intermediate in Organic Synthesis:
5-AMinoMethyl-nicotinonitrile is also used as an intermediate in the synthesis of other organic compounds, contributing to the development of new chemical entities and materials.
Used in Drug Development:
5-Aminomethyl-nicotinonitrile has been studied for its potential use in the treatment of various medical conditions. Its ability to modify drug properties makes it a promising candidate for the development of new therapeutic agents.
However, it is important to handle 5-Aminomethyl-nicotinonitrile with caution, as it may pose health risks if not properly managed. Proper safety measures should be taken to minimize any potential hazards associated with its use.

Upstream product

• 1108724-20-4 tert-butyl (5-cyanopyridin-3-yl)methylcarbamate 
• 135124-71-9 5-(hydroxymethyl)pyridine-3-carbonitrile 
• 562074-59-3 5-(chloromethyl)nicotinonitrile hydrochloride 

Relevant academic research and scientific papers

(3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING

The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease. (Formula)

CB1 MODULATOR COMPOUNDS

Novel compounds of structural formula (I) are disclosed. As modulators of the Cannabinoid-1 (CB1) receptor, these compounds are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. As such, compounds of the present invention are useful as in the treatment, prevention and suppression of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders (e.g., multiple sclerosis, Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis), cerebral vascular accidents, head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, particularly to opiates, alcohol, and nicotine. The compounds are also useful for the treatment of obesity or eating disorders associated with excessive food intake and complications associated therewith.

5-substituted-6-aminopyrimidine derivatives

A compound of the formula: STR1 in which R1 is --OH or --NH2 ; R2 is a halogen or --CN; R3 is a halogen or --CN; and n is one of the integers 1, 2 or 3; or a pharmaceutically acceptable salt thereof, are useful as antithrombotic agents.